Dr. Gregg Silverman: The Microbiome and SLE
PLAN: Perceptions + Outcomes of Pregnancy + Lactation in Patients w/ Rheumatic Diseases. #ACR17 @RheumNow #355 https://t.co/sA9TqICwyh
— Dr. Rachel Tate (@DrRachelTate) November 5, 2017
My friend @Linherski's Goutpro learning tool for trainees. #ACR17 @RheumNow #117 pic.twitter.com/6s1lIP9AZe
— Dr. Paul Sufka (@psufka) November 5, 2017
Risk of a 2nd (recurrence) cancer after a 1st cancer is not increased with biologic use. #ACR17 Abstr 11L pic.twitter.com/kjWnAK2QN4
— Dr. John Cush (@RheumNow) November 6, 2017
DASH diet lowering urate in specific subgroups #ACR17 @rheumnow pic.twitter.com/boEc3UKsny
— Dr Irwin Lim (@_connectedcare) November 5, 2017
Maternal #biologic use did not increase risk for opportunistic infections in #newborns https://t.co/1Iaj1awDK0 #ACR17 pic.twitter.com/3GGIYVu5Bw
— Healio Rheumatology (@HealioRheum) November 6, 2017
Dr J Merrill Blisibimod not meet SRI-6 endpt but did dec steroids, dec. Upr:Ucr& dsDNA, inc.C3/C4 #ACR17 @rheumnow #888 pic.twitter.com/O87jtn40p1
— k dao (@KDAO2011) November 5, 2017
Impressive result for Mepolizumab in EGPA #ACR17 @rheumnow pic.twitter.com/YhqvGLwpMu
— Dr Irwin Lim (@_connectedcare) November 5, 2017
Large trial, long fu. Celecoxib does NOT cause more CVS issues than Naproxen or Ibuprofen #ACR17 @rheumnow pic.twitter.com/mszgPO3P0D
— Dr Irwin Lim (@_connectedcare) November 5, 2017
Giant cell arteritis is an ancient disease.. But in 1932 Horton & colleges described the disease | @LCalabreseDO pic.twitter.com/C5lJ1IEiWb
— Dr.Martínez (@MtzReuma) November 6, 2017
AxSpA- Does obesity affect response to TNF blockers? #ACR17 #AnkylosingSpondylitis @RheumNow pic.twitter.com/ubmQHTqdVq
— Dr. shashank akerkar (@doctorakerkar) November 6, 2017
Therapies to look forward to in #AnkylosingSpondylitis #ACR17 pic.twitter.com/h9uZQ08wbD
— Dr. shashank akerkar (@doctorakerkar) November 6, 2017
More long term safety data with Biologics in this abstract looking at infections in long term users in Latin America #ACR17 @rheumnow #541 pic.twitter.com/HsIAzEymBw
— William Shergy (@WShergy) November 5, 2017
Dr. Jack Cush: Plenary Session on Bisphosphonate Holiday
IFN kappa, a key driver of enhanced inflamm responses in skin lupus @RheumNow #ACR17 #897
— Ian N Bruce (@Lupusdoc) November 6, 2017
The reason why Etoricoxib is preferred NSAID in #AnkylosingSpondylitis #ACR17 @RheumNow pic.twitter.com/gbit47We7n
— Dr. shashank akerkar (@doctorakerkar) November 6, 2017
What data are you reporting for MACRA? #ACR17 @RheumNow
— Dr. Rachel Tate (@DrRachelTate) November 6, 2017
#GAMECHANGERS. No new way to image or investigate for suspected prosthetic joint involvement #acr17 @rheumnow #282 pic.twitter.com/XYMvCPPEq7
— Janet (@Janetbirdope) November 6, 2017
Dr. Cassandra Calabrese: Efficacy of Flu Vaccine on RA Patients
RheumNow meets up with Great PA's and NP's at #ACR17 pic.twitter.com/hE1djZQvz3
— Dr. John Cush (@RheumNow) November 6, 2017
Dr. Jack Cush: New Biologics, Pregnancy in AS/SpA, JAK, Gout, Psoriatic Arthritis and More
Dr. John Goldman: Anthony Fauci, MD, Infectious Disease Opening Lecture
12% progression in 2yrs to AS from nrAxSpA #ACR17 @rheumnow pic.twitter.com/QcFR8zzRXF
— Dr Irwin Lim (@_connectedcare) November 6, 2017
High CRP main predictor of progression of nrAxSpA to AS #ACR17 @RheumNow pic.twitter.com/E84Wfj7B1e
— Dr. shashank akerkar (@doctorakerkar) November 6, 2017
Another study discussing progression to AS. Slightly inflammatory last comment #ACR17 @rheumnow pic.twitter.com/UMVZf1rKET
— Dr Irwin Lim (@_connectedcare) November 6, 2017
Dr. Olga Petryna: FRAME Study
Presentation of the arthritis type of checkpoint inhibitor adverse events is often very inflammatory #ACR17 @RheumNow pic.twitter.com/0LgnDfE7nJ
— Philip Robinson (@philipcrobinson) November 5, 2017